Micrus Endovascular Fiscal Fourth Quarter Neurovascular Revenues Increase 24% to $25.6 Million
Micrus Endovascular Fiscal Fourth Quarter Neurovascular Revenues Increase 24% to $25.6 Million
SAN JOSE, Calif.—-Micrus Endovascular Corporation today reported financial results for the three and 12 months ended March 31, 2010 and introduced fiscal 2011 financial guidance.
Read more on Business Wire via Yahoo! Finance





